Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Tirzepatide

Efficacy and Safety of Tirzepatide for Weight Management

Eli Lilly · Phase 3 · Active, not recruiting · Enrollment 440

NCT06918405

Participants reaching a weight loss threshold

Participants reaching threshold, %

Source: Cited trial source. The denominator is the source figure, when it states one.

No selected arm reports a responder percent.

Show as table
Arm≥5%≥10%≥15%≥20%
Tirzepatide armn/rn/rn/rn/r

Not shown

  • Tirzepatide arm: endpoint not reported